Corpus
PascalFrancis
Racine
Corpus
Checkpoint
PascalFrancis
Racine
PascalFrancis
Exploration
Accueil
Racine
Racine

Movement Disorders (revue)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Parkinsonian syndrome induced by amlodipine: Case report

Identifieur interne : 002673 ( PascalFrancis/Corpus ); précédent : 002672; suivant : 002674

Parkinsonian syndrome induced by amlodipine: Case report

Auteurs : Hélio A. G. Teive ; Francisco M. B. Germiniani ; Lineu César Werneck

Source :

RBID : Pascal:02-0456884

Descripteurs français

English descriptors

Abstract

An elderly patient who developed marked symptoms of parkinsonism in response to amlodipine for the treatment of arterial systemic hypertension is described. She had a complete reversal of her motor symptoms after discontinuation of the drug.

Notice en format standard (ISO 2709)

Pour connaître la documentation sur le format Inist Standard.

pA  
A01 01  1    @0 0885-3185
A03   1    @0 Mov. disord.
A05       @2 17
A06       @2 4
A08 01  1  ENG  @1 Parkinsonian syndrome induced by amlodipine: Case report
A11 01  1    @1 TEIVE (Hélio A. G.)
A11 02  1    @1 GERMINIANI (Francisco M. B.)
A11 03  1    @1 WERNECK (Lineu César)
A14 01      @1 Movement Disorders Unit, Neurology Service Hospital de Clínicas, Federal University of Paraná @2 Curitiba, PR @3 BRA @Z 1 aut. @Z 2 aut. @Z 3 aut.
A20       @1 833-835
A21       @1 2002
A23 01      @0 ENG
A43 01      @1 INIST @2 20953 @5 354000108922560390
A44       @0 0000 @1 © 2002 INIST-CNRS. All rights reserved.
A45       @0 20 ref.
A47 01  1    @0 02-0456884
A60       @1 P @3 EC
A61       @0 A
A64 01  1    @0 Movement disorders
A66 01      @0 USA
C01 01    ENG  @0 An elderly patient who developed marked symptoms of parkinsonism in response to amlodipine for the treatment of arterial systemic hypertension is described. She had a complete reversal of her motor symptoms after discontinuation of the drug.
C02 01  X    @0 002B02U01
C02 02  X    @0 235
C03 01  X  FRE  @0 Parkinsonisme @2 NM @5 01
C03 01  X  ENG  @0 Parkinsonism @2 NM @5 01
C03 01  X  SPA  @0 Parkinson síndrome @2 NM @5 01
C03 02  X  FRE  @0 Amlodipine @2 NK @2 FR @5 04
C03 02  X  ENG  @0 Amlodipine @2 NK @2 FR @5 04
C03 02  X  SPA  @0 Amlodipino @2 NK @2 FR @5 04
C03 03  X  FRE  @0 Chimiothérapie @5 05
C03 03  X  ENG  @0 Chemotherapy @5 05
C03 03  X  SPA  @0 Quimioterapia @5 05
C03 04  X  FRE  @0 Antihypertenseur @5 06
C03 04  X  ENG  @0 Antihypertensive agent @5 06
C03 04  X  SPA  @0 Antihipertensivo @5 06
C03 05  X  FRE  @0 Antagoniste calcium @5 07
C03 05  X  ENG  @0 Calcium antagonist @5 07
C03 05  X  SPA  @0 Antagonista calcio @5 07
C03 06  X  FRE  @0 Hypertension artérielle @5 10
C03 06  X  ENG  @0 Hypertension @5 10
C03 06  X  SPA  @0 Hipertensión arterial @5 10
C03 07  X  FRE  @0 Etude cas @5 17
C03 07  X  ENG  @0 Case study @5 17
C03 07  X  SPA  @0 Estudio caso @5 17
C03 08  X  FRE  @0 Traitement @5 18
C03 08  X  ENG  @0 Treatment @5 18
C03 08  X  SPA  @0 Tratamiento @5 18
C03 09  X  FRE  @0 Toxicité @5 19
C03 09  X  ENG  @0 Toxicity @5 19
C03 09  X  SPA  @0 Toxicidad @5 19
C03 10  X  FRE  @0 Personne âgée @5 20
C03 10  X  ENG  @0 Elderly @5 20
C03 10  X  SPA  @0 Anciano @5 20
C03 11  X  FRE  @0 Femelle @5 21
C03 11  X  ENG  @0 Female @5 21
C03 11  X  SPA  @0 Hembra @5 21
C03 12  X  FRE  @0 Dihydropyridine dérivé @5 27
C03 12  X  ENG  @0 Dihydropyridine derivatives @5 27
C03 12  X  SPA  @0 Dihidropiridine derivado @5 27
C07 01  X  FRE  @0 Homme
C07 01  X  ENG  @0 Human
C07 01  X  SPA  @0 Hombre
C07 02  X  FRE  @0 Système nerveux pathologie @5 37
C07 02  X  ENG  @0 Nervous system diseases @5 37
C07 02  X  SPA  @0 Sistema nervioso patología @5 37
C07 03  X  FRE  @0 Trouble neurologique @5 38
C07 03  X  ENG  @0 Neurological disorder @5 38
C07 03  X  SPA  @0 Trastorno neurológico @5 38
C07 04  X  FRE  @0 Appareil circulatoire pathologie @5 61
C07 04  X  ENG  @0 Cardiovascular disease @5 61
C07 04  X  SPA  @0 Aparato circulatorio patología @5 61
N21       @1 266
N82       @1 PSI

Format Inist (serveur)

NO : PASCAL 02-0456884 INIST
ET : Parkinsonian syndrome induced by amlodipine: Case report
AU : TEIVE (Hélio A. G.); GERMINIANI (Francisco M. B.); WERNECK (Lineu César)
AF : Movement Disorders Unit, Neurology Service Hospital de Clínicas, Federal University of Paraná/Curitiba, PR/Brésil (1 aut., 2 aut., 3 aut.)
DT : Publication en série; Etude de cas, cas et faits cliniques; Niveau analytique
SO : Movement disorders; ISSN 0885-3185; Etats-Unis; Da. 2002; Vol. 17; No. 4; Pp. 833-835; Bibl. 20 ref.
LA : Anglais
EA : An elderly patient who developed marked symptoms of parkinsonism in response to amlodipine for the treatment of arterial systemic hypertension is described. She had a complete reversal of her motor symptoms after discontinuation of the drug.
CC : 002B02U01; 235
FD : Parkinsonisme; Amlodipine; Chimiothérapie; Antihypertenseur; Antagoniste calcium; Hypertension artérielle; Etude cas; Traitement; Toxicité; Personne âgée; Femelle; Dihydropyridine dérivé
FG : Homme; Système nerveux pathologie; Trouble neurologique; Appareil circulatoire pathologie
ED : Parkinsonism; Amlodipine; Chemotherapy; Antihypertensive agent; Calcium antagonist; Hypertension; Case study; Treatment; Toxicity; Elderly; Female; Dihydropyridine derivatives
EG : Human; Nervous system diseases; Neurological disorder; Cardiovascular disease
SD : Parkinson síndrome; Amlodipino; Quimioterapia; Antihipertensivo; Antagonista calcio; Hipertensión arterial; Estudio caso; Tratamiento; Toxicidad; Anciano; Hembra; Dihidropiridine derivado
LO : INIST-20953.354000108922560390
ID : 02-0456884

Links to Exploration step

Pascal:02-0456884

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en" level="a">Parkinsonian syndrome induced by amlodipine: Case report</title>
<author>
<name sortKey="Teive, Helio A G" sort="Teive, Helio A G" uniqKey="Teive H" first="Hélio A. G." last="Teive">Hélio A. G. Teive</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Movement Disorders Unit, Neurology Service Hospital de Clínicas, Federal University of Paraná</s1>
<s2>Curitiba, PR</s2>
<s3>BRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Germiniani, Francisco M B" sort="Germiniani, Francisco M B" uniqKey="Germiniani F" first="Francisco M. B." last="Germiniani">Francisco M. B. Germiniani</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Movement Disorders Unit, Neurology Service Hospital de Clínicas, Federal University of Paraná</s1>
<s2>Curitiba, PR</s2>
<s3>BRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Werneck, Lineu Cesar" sort="Werneck, Lineu Cesar" uniqKey="Werneck L" first="Lineu César" last="Werneck">Lineu César Werneck</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Movement Disorders Unit, Neurology Service Hospital de Clínicas, Federal University of Paraná</s1>
<s2>Curitiba, PR</s2>
<s3>BRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">INIST</idno>
<idno type="inist">02-0456884</idno>
<date when="2002">2002</date>
<idno type="stanalyst">PASCAL 02-0456884 INIST</idno>
<idno type="RBID">Pascal:02-0456884</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">002673</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en" level="a">Parkinsonian syndrome induced by amlodipine: Case report</title>
<author>
<name sortKey="Teive, Helio A G" sort="Teive, Helio A G" uniqKey="Teive H" first="Hélio A. G." last="Teive">Hélio A. G. Teive</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Movement Disorders Unit, Neurology Service Hospital de Clínicas, Federal University of Paraná</s1>
<s2>Curitiba, PR</s2>
<s3>BRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Germiniani, Francisco M B" sort="Germiniani, Francisco M B" uniqKey="Germiniani F" first="Francisco M. B." last="Germiniani">Francisco M. B. Germiniani</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Movement Disorders Unit, Neurology Service Hospital de Clínicas, Federal University of Paraná</s1>
<s2>Curitiba, PR</s2>
<s3>BRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Werneck, Lineu Cesar" sort="Werneck, Lineu Cesar" uniqKey="Werneck L" first="Lineu César" last="Werneck">Lineu César Werneck</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Movement Disorders Unit, Neurology Service Hospital de Clínicas, Federal University of Paraná</s1>
<s2>Curitiba, PR</s2>
<s3>BRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</analytic>
<series>
<title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
<imprint>
<date when="2002">2002</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Amlodipine</term>
<term>Antihypertensive agent</term>
<term>Calcium antagonist</term>
<term>Case study</term>
<term>Chemotherapy</term>
<term>Dihydropyridine derivatives</term>
<term>Elderly</term>
<term>Female</term>
<term>Hypertension</term>
<term>Parkinsonism</term>
<term>Toxicity</term>
<term>Treatment</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr">
<term>Parkinsonisme</term>
<term>Amlodipine</term>
<term>Chimiothérapie</term>
<term>Antihypertenseur</term>
<term>Antagoniste calcium</term>
<term>Hypertension artérielle</term>
<term>Etude cas</term>
<term>Traitement</term>
<term>Toxicité</term>
<term>Personne âgée</term>
<term>Femelle</term>
<term>Dihydropyridine dérivé</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">An elderly patient who developed marked symptoms of parkinsonism in response to amlodipine for the treatment of arterial systemic hypertension is described. She had a complete reversal of her motor symptoms after discontinuation of the drug.</div>
</front>
</TEI>
<inist>
<standard h6="B">
<pA>
<fA01 i1="01" i2="1">
<s0>0885-3185</s0>
</fA01>
<fA03 i2="1">
<s0>Mov. disord.</s0>
</fA03>
<fA05>
<s2>17</s2>
</fA05>
<fA06>
<s2>4</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG">
<s1>Parkinsonian syndrome induced by amlodipine: Case report</s1>
</fA08>
<fA11 i1="01" i2="1">
<s1>TEIVE (Hélio A. G.)</s1>
</fA11>
<fA11 i1="02" i2="1">
<s1>GERMINIANI (Francisco M. B.)</s1>
</fA11>
<fA11 i1="03" i2="1">
<s1>WERNECK (Lineu César)</s1>
</fA11>
<fA14 i1="01">
<s1>Movement Disorders Unit, Neurology Service Hospital de Clínicas, Federal University of Paraná</s1>
<s2>Curitiba, PR</s2>
<s3>BRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
</fA14>
<fA20>
<s1>833-835</s1>
</fA20>
<fA21>
<s1>2002</s1>
</fA21>
<fA23 i1="01">
<s0>ENG</s0>
</fA23>
<fA43 i1="01">
<s1>INIST</s1>
<s2>20953</s2>
<s5>354000108922560390</s5>
</fA43>
<fA44>
<s0>0000</s0>
<s1>© 2002 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45>
<s0>20 ref.</s0>
</fA45>
<fA47 i1="01" i2="1">
<s0>02-0456884</s0>
</fA47>
<fA60>
<s1>P</s1>
<s3>EC</s3>
</fA60>
<fA61>
<s0>A</s0>
</fA61>
<fA64 i1="01" i2="1">
<s0>Movement disorders</s0>
</fA64>
<fA66 i1="01">
<s0>USA</s0>
</fA66>
<fC01 i1="01" l="ENG">
<s0>An elderly patient who developed marked symptoms of parkinsonism in response to amlodipine for the treatment of arterial systemic hypertension is described. She had a complete reversal of her motor symptoms after discontinuation of the drug.</s0>
</fC01>
<fC02 i1="01" i2="X">
<s0>002B02U01</s0>
</fC02>
<fC02 i1="02" i2="X">
<s0>235</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE">
<s0>Parkinsonisme</s0>
<s2>NM</s2>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG">
<s0>Parkinsonism</s0>
<s2>NM</s2>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA">
<s0>Parkinson síndrome</s0>
<s2>NM</s2>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE">
<s0>Amlodipine</s0>
<s2>NK</s2>
<s2>FR</s2>
<s5>04</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG">
<s0>Amlodipine</s0>
<s2>NK</s2>
<s2>FR</s2>
<s5>04</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA">
<s0>Amlodipino</s0>
<s2>NK</s2>
<s2>FR</s2>
<s5>04</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE">
<s0>Chimiothérapie</s0>
<s5>05</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG">
<s0>Chemotherapy</s0>
<s5>05</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA">
<s0>Quimioterapia</s0>
<s5>05</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE">
<s0>Antihypertenseur</s0>
<s5>06</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG">
<s0>Antihypertensive agent</s0>
<s5>06</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA">
<s0>Antihipertensivo</s0>
<s5>06</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE">
<s0>Antagoniste calcium</s0>
<s5>07</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG">
<s0>Calcium antagonist</s0>
<s5>07</s5>
</fC03>
<fC03 i1="05" i2="X" l="SPA">
<s0>Antagonista calcio</s0>
<s5>07</s5>
</fC03>
<fC03 i1="06" i2="X" l="FRE">
<s0>Hypertension artérielle</s0>
<s5>10</s5>
</fC03>
<fC03 i1="06" i2="X" l="ENG">
<s0>Hypertension</s0>
<s5>10</s5>
</fC03>
<fC03 i1="06" i2="X" l="SPA">
<s0>Hipertensión arterial</s0>
<s5>10</s5>
</fC03>
<fC03 i1="07" i2="X" l="FRE">
<s0>Etude cas</s0>
<s5>17</s5>
</fC03>
<fC03 i1="07" i2="X" l="ENG">
<s0>Case study</s0>
<s5>17</s5>
</fC03>
<fC03 i1="07" i2="X" l="SPA">
<s0>Estudio caso</s0>
<s5>17</s5>
</fC03>
<fC03 i1="08" i2="X" l="FRE">
<s0>Traitement</s0>
<s5>18</s5>
</fC03>
<fC03 i1="08" i2="X" l="ENG">
<s0>Treatment</s0>
<s5>18</s5>
</fC03>
<fC03 i1="08" i2="X" l="SPA">
<s0>Tratamiento</s0>
<s5>18</s5>
</fC03>
<fC03 i1="09" i2="X" l="FRE">
<s0>Toxicité</s0>
<s5>19</s5>
</fC03>
<fC03 i1="09" i2="X" l="ENG">
<s0>Toxicity</s0>
<s5>19</s5>
</fC03>
<fC03 i1="09" i2="X" l="SPA">
<s0>Toxicidad</s0>
<s5>19</s5>
</fC03>
<fC03 i1="10" i2="X" l="FRE">
<s0>Personne âgée</s0>
<s5>20</s5>
</fC03>
<fC03 i1="10" i2="X" l="ENG">
<s0>Elderly</s0>
<s5>20</s5>
</fC03>
<fC03 i1="10" i2="X" l="SPA">
<s0>Anciano</s0>
<s5>20</s5>
</fC03>
<fC03 i1="11" i2="X" l="FRE">
<s0>Femelle</s0>
<s5>21</s5>
</fC03>
<fC03 i1="11" i2="X" l="ENG">
<s0>Female</s0>
<s5>21</s5>
</fC03>
<fC03 i1="11" i2="X" l="SPA">
<s0>Hembra</s0>
<s5>21</s5>
</fC03>
<fC03 i1="12" i2="X" l="FRE">
<s0>Dihydropyridine dérivé</s0>
<s5>27</s5>
</fC03>
<fC03 i1="12" i2="X" l="ENG">
<s0>Dihydropyridine derivatives</s0>
<s5>27</s5>
</fC03>
<fC03 i1="12" i2="X" l="SPA">
<s0>Dihidropiridine derivado</s0>
<s5>27</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE">
<s0>Homme</s0>
</fC07>
<fC07 i1="01" i2="X" l="ENG">
<s0>Human</s0>
</fC07>
<fC07 i1="01" i2="X" l="SPA">
<s0>Hombre</s0>
</fC07>
<fC07 i1="02" i2="X" l="FRE">
<s0>Système nerveux pathologie</s0>
<s5>37</s5>
</fC07>
<fC07 i1="02" i2="X" l="ENG">
<s0>Nervous system diseases</s0>
<s5>37</s5>
</fC07>
<fC07 i1="02" i2="X" l="SPA">
<s0>Sistema nervioso patología</s0>
<s5>37</s5>
</fC07>
<fC07 i1="03" i2="X" l="FRE">
<s0>Trouble neurologique</s0>
<s5>38</s5>
</fC07>
<fC07 i1="03" i2="X" l="ENG">
<s0>Neurological disorder</s0>
<s5>38</s5>
</fC07>
<fC07 i1="03" i2="X" l="SPA">
<s0>Trastorno neurológico</s0>
<s5>38</s5>
</fC07>
<fC07 i1="04" i2="X" l="FRE">
<s0>Appareil circulatoire pathologie</s0>
<s5>61</s5>
</fC07>
<fC07 i1="04" i2="X" l="ENG">
<s0>Cardiovascular disease</s0>
<s5>61</s5>
</fC07>
<fC07 i1="04" i2="X" l="SPA">
<s0>Aparato circulatorio patología</s0>
<s5>61</s5>
</fC07>
<fN21>
<s1>266</s1>
</fN21>
<fN82>
<s1>PSI</s1>
</fN82>
</pA>
</standard>
<server>
<NO>PASCAL 02-0456884 INIST</NO>
<ET>Parkinsonian syndrome induced by amlodipine: Case report</ET>
<AU>TEIVE (Hélio A. G.); GERMINIANI (Francisco M. B.); WERNECK (Lineu César)</AU>
<AF>Movement Disorders Unit, Neurology Service Hospital de Clínicas, Federal University of Paraná/Curitiba, PR/Brésil (1 aut., 2 aut., 3 aut.)</AF>
<DT>Publication en série; Etude de cas, cas et faits cliniques; Niveau analytique</DT>
<SO>Movement disorders; ISSN 0885-3185; Etats-Unis; Da. 2002; Vol. 17; No. 4; Pp. 833-835; Bibl. 20 ref.</SO>
<LA>Anglais</LA>
<EA>An elderly patient who developed marked symptoms of parkinsonism in response to amlodipine for the treatment of arterial systemic hypertension is described. She had a complete reversal of her motor symptoms after discontinuation of the drug.</EA>
<CC>002B02U01; 235</CC>
<FD>Parkinsonisme; Amlodipine; Chimiothérapie; Antihypertenseur; Antagoniste calcium; Hypertension artérielle; Etude cas; Traitement; Toxicité; Personne âgée; Femelle; Dihydropyridine dérivé</FD>
<FG>Homme; Système nerveux pathologie; Trouble neurologique; Appareil circulatoire pathologie</FG>
<ED>Parkinsonism; Amlodipine; Chemotherapy; Antihypertensive agent; Calcium antagonist; Hypertension; Case study; Treatment; Toxicity; Elderly; Female; Dihydropyridine derivatives</ED>
<EG>Human; Nervous system diseases; Neurological disorder; Cardiovascular disease</EG>
<SD>Parkinson síndrome; Amlodipino; Quimioterapia; Antihipertensivo; Antagonista calcio; Hipertensión arterial; Estudio caso; Tratamiento; Toxicidad; Anciano; Hembra; Dihidropiridine derivado</SD>
<LO>INIST-20953.354000108922560390</LO>
<ID>02-0456884</ID>
</server>
</inist>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/PascalFrancis/Corpus

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002673 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Corpus/biblio.hfd -nk 002673 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    PascalFrancis
   |étape=   Corpus
   |type=    RBID
   |clé=     Pascal:02-0456884
   |texte=   Parkinsonian syndrome induced by amlodipine: Case report
}}
Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024